The Adriamycin derivative, cyanomorpholinoadriamycin (CMA) was reacted with DNA In vitro to form apparent Interstrand crosslinks. The extent of Interstrand crosslink formation was monitored by a gel electrophoresis assay and maximal crosslinking of DNA was observed within 1 hr with 5 /xM of drug. The interstrand crosslinks were heat labile, with a midpoint melting temperature of 70°C (10 min exposure to heat) In 45% formamlde. When CMA-induced adducts were detected as blockages of X-exonuclease, 12 blockage sites were observed with 8 being prior to 5'-GG sequences, one prior to 5'-CC, one prior to 5'-GC and 2 at unresolved combinations of these sequences. These exonuclease-detected blockages reveal the same sites of CMA-lnduced crosslinking as detected by In vitro transcription footprinting and primerextension blockages on single strand DNA, where the blockages at 5-GG and 5'-CC were Identified as sites of Intrastrand crosslinking and the 5'-GC blockage as a probable site of Interstrand crosslinking. The thermal stability of both types of crosslink (10 min exposure to heat) ranged from 63 -70°C at individual sites. High levels of adduct were detected with poly (dG-dC) but not with poly (dl-dC). These results suggest adduct formation involving an aminal linkage between the 3 position of the morphollno moiety and N 2 of guanlne.
INTRODUCTION
Cancer treatment in recent years has greatly benefited from the therapeutic value of the anthracycline antibiotics, in particular, Adriamycin. Adriamycin exhibits an antitumour activity against a wide spectrum of neoplasia, including both solid and haematological tumours (1) (2) (3) (4) . Though generally used in combination regimes, Adriamycin remains as one of the single most effective agents in the treatment of breast cancer (2, 3) . Its use however is restricted by a severe cumulative dose dependent cardiotoxicity which limits the total level of drug administerable to 55Omg/ni?, and also by the onset of myelosuppression, aquired resistance and a wide spectrum of less major side effects which are often encountered (5, 6) .
With a view to increasing tumour potency and ameliorating toxicity, much research has been directed at modification of successful agents such as Adriamycin in an attempt to synthesise more therapeutic drugs. Of the hundreds of anthracycline derivatives synthesised to date, this approach has met with limited success with only several reaching clinical use (7) (8) (9) . The synthesis of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin (CMA, Figure 1 ) as a potential DNA alkylating agent (10) marked a new approach to achieve these goals. CMA has been demonstrated to be up to 1400 times more potent than Adriamycin in a number of cell lines (11, 12) and showed similar activity in vivo against tumours in mice (10, 11) . Further studies at the DNA level have revealed the rapid formation of DNA interstrand crosslinks upon exposure of cells to CMA, the appearance of which correlates well with drug cytotoxicity (11) .
We have recently utilised an in vitro transcription assay to reveal the rapid and sequence specific binding of CMA to DNA (13, 14) . A preference of CMA binding at GG sequences was seen and appeared to reflect the formation of intrastrand crosslinks while binding at GC sites was of lower intensity and may represent interstrand crosslinks through adjacent guanine residues on opposite DNA strands (14) . We now report the thermal stability of both intra-and interstrand crosslinks induced by CMA in vitro, and show that both types of crosslinks are heat labile, with a melting temperature of 70°C. The significance of this heat lability is that it precludes the use of primer-extension procedures which would otherwise be used to probe the location and extent of these adducts. We also report on the composition of the adduct and its reactive site on guanine.
Rad (CA, USA). Restriction enzymes and Klenow fragment were from New England Biolabs (CT, USA) while Genetic Technology Grade agarose was from ICN Biomedicals (CA, USA). Nensorb-20 columns were purchased from Du Pont (DE, USA) and [ar^PJdATP and Hyperfilm were from Amersham (UK). Xexonuclease was from BRL (MD, USA).
Interstrand crosslinking
The method used to study CMA crosslinking was based on that employed by Hartley et al. (17) . The 2999 bp plasmid, pSP64 was linearised with Eco RI prior to 3'-end labelling by reaction with [« 32 P]dATP and Klenow fragment of E.coli DNA polymerase 1 (18) . Unincorporated label and protein was removed by passing the labelling reaction through an Nensorb-20 column. The eluted DNA was lyophilised prior to resuspension in TE buffer and sonicated calf thymus DNA to a concentration of 300/tM bp. A 100/tl solution containing the 3'-labelled fragment in a reaction buffer (40mM Tris, pH 8.0, lOOmM KC1, 3mM MgCl 2 , O.lmM EDTA) was divided into two aliquots. Reaction buffer was added to one while CMA was added to the other to a final concentration of 5/iM (drug:bp = 0.2) and both reactions incubated at 37°C. Aliquots (5/tl) were removed from both reactions at time intervals and the reaction terminated by the addition of an equal volume of loading dye (90% formamide, lOmM EDTA, 0.1 % xylene cyanol and 0.1 % bromophenol blue) and stored on ice. Reactions were denatured at 70°C for 5 min and quenched on ice prior to loading of samples onto an 0.8% agarose gel. Electrophoresis was performed on a 40 cm horizontal gel apparatus in TAE buffer at 45V for 13 hours. The gel was subsequendy dried prior to autoradiography and band quantitation using a Molecular Dynamics (CA, USA) Model 400B Phosphorlmager.
Crosslinking temperature stability DNA was reacted with 10/iM CMA as above for 90 min at 37°C. Unreacted drug was subsequently removed by phenol/chloroform extraction and the DNA precipitated in the presence of 10/tg glycogen as an inert carrier. The DNA was resuspended in reaction buffer and an equal volume of loading dye (90% formamide, 10 mM EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol). Aliquots (10/J) were exposed to increasing temperatures (10 min) then placed on ice prior to loading onto a 0.8% agarose gel, electrophoresis and autoradiography as above. Denaturation was carried out in the presence of formamide in order to reduce the melting temperature of the DNA to below that of the adducts.
Exonuclease digestion pCCl was digested with Eco RI and Pvu II to release a fragment of 186 bp. The fragment was isolated by electrophoresis on a low melting agarose gel and subsequently 3'-end labelled by reaction with [a^PJdATP and Klenow fragment as above. Labelled 186bp fragment (25 /iM bp) was reacted in the presence of 1 /tM CMA in reaction buffer for one hour. The reacted DNA was subsequently extracted with phenol/chloroform and ethanol precipitated prior to resuspension in reaction buffer. Aliquots (10/tl) were removed and incubated for 10 min at temperatures between 60 and 95°C prior to re-annealing by cooling to 20°C over 1 hr. Heat treated DNA (2.5 fil) was reacted with Xexonuclease in a buffer comprising 67 mM glycine pH 9.4, 2.5 mM MgCl 2 and 50 /tg/mL BSA, for 60 min at 37°C. Reactions were terminated by the addition of of an equal volume of formamide loading buffer and subjected to electrophoresis on an 8% denaturing poly aery lamide gel. The gel was fixed and dried as described previously (19) . Autoradiography and band quantitation were as described above.
Spectral studies CMA (24 pM) was reacted with synthetic polynucleotides poly(dG-dC) and poly(dl-dC) (150 /tM bp) for 3.5 hours as described above. Non-bound drug was removed by two extractions into phenol and one into chloroform. The DNA was precipitated, resuspended into TE buffer, pH 7.5 and the absorbance spectrum measured on a Cary 118 spectrophotometer.
RESULTS

DNA crosslinking by CMA
It has been widely reported that CMA induces interstrand crosslinks on DNA (11, 12, (20) (21) (22) (23) and we have used a crosslinking assay (17) to monitor the formation of such crosslinks. In this assay interstrand DNA crosslinking was detected as a resistance of the DNA strands to separate under normal DNA denaturing conditions. It should be noted however that this procedure does not completely unambiguously confirm the existence of interstrand crosslinks. It is formally possible that a monoadduct could stabilise the local region of DNA to the denaturing conditions employed. This interpretation is not appropriate in the present instance since CMA-induced interstrand crosslinks have previously been confirmed in vitro by other means (11, 20) . A crosslinking gel which demonstrates the time-dependent formation of interstrand crosslinks on an end-labelled DNA fragment, is shown in Figure 2 . Control DNA incubated in the absence of drug migrates slowly as a double-stranded band on an agarose gel when not denatured, while incubation of DNA with 5/iM CMA results in a migration retardation of the duplex band compared with the control. Exposure of DNA to 70°C resulted in denaturation of control DNA as detected by an altered migration of the band on the agarose gel, due to a transition from double-strand to single-strand DNA. In contrast to the control DNA, exposure of DNA to CMA for increasing time showed a time-dependent resistance to denaturation, indicative of the formation of DNA crosslinks by CMA. DNA crosslinking induced by CMA was rapid, with 20% of DNA containing at least one crosslink within 5 min, and with maximal crosslinking (90%) within 60 min of exposure to the drug.
Heat stability of CMA crosslinks
The stability of the DNA crosslinks induced by CMA was investigated after it was revealed that no crosslinking was detected following DNA denaturation at elevated temperatures (data not shown). To ensure that the temperature profile obtained represented the stability of the CMA crosslink, and not merely stabilisation of the DNA due to the presence of intercalated drug, unreacted and intercalated drug was removed by a phenol/chloroform extaction prior to assay. Figure 3 shows the lability of the DNA crosslink induced by CMA as detected by the temperature-dependent separation of double-strand DNA. CMA-treated DNA was more resistant to strand separation than control DNA though almost total separation was apparent following exposure to 75 °C and above for 10 min.
Quantitation of the stability of the DNA duplex in the presence and absence of CMA is shown in Figure 4 for 5 min and 10 min exposure of the DNA to different temperatures. Exposure of control DNA for both 5 or 10 min periods revealed a sharp transition from double-strand to single-strand DNA with a midpoint melting temperature at 67 °C. For CMA-induced crosslinked DNA, the midpoint melting temperature was 74°C (5 min exposure to each temperature) but this decreased to 70°C when heated for 10 min at each temperature. X-Exonuclease sequence specificity Lambda exonuclease, a 5'-exonuclease, was used to reveal the heat lability of sequence specific blockages induced by CMA in DNA. Control DNA incubated in the absence of CMA was digested almost completely upon exposure to the exonuclease as seen by the lack of radioactivity in control lanes of Figure 5 . In contrast, CMA-treated DNA was resistant to enzyme digestion, as evidenced by the presence of specific bands not present in the control lanes. Inhibition at most sites appears as staggered blockages over 3-5 nucleotides. At individual blockage sites there is a general trend of impairment of exonuclease digestion, with the highest intensity blockage being the first encountered by the nuclease with subsequent blockages reducing in intensity. Analysis of the fraction of DNA molecules inhibiting enzyme digestion is shown in Figure 6 as a function of the DNA sequence. Of the 12 exonuclease sites observed, 8 are associated with isolated 5'-GG sequences, one with an isolated CC sequence, one at an isolated 5'-GC sequence and two others at unresolved combinations of these sites. Blockage at GG sites is consistent with inhibition of enzyme digestion due to intrastrand crosslinks between adjacent guanine residues on the degraded strand, while CC blockages most likely represent blockages due to similar crosslinks on the non-degraded strand. Enzyme inhibition was evident prior to all GG and CC sequences (total of 11) but not prior to all isolated GC sites (1 of 5). All major blockages occur 3-5 bases prior to the drug site with decreasing blockages up to the apparent drug binding site.
Heat stability of individual CMA sites
The heat stability of CMA adducts and crosslinks was assessed by the ability of X-exonuclease to digest CMA-treated DNA which had been exposed to elevated temperatures. As with the crosslinking assay, any unreacted drug which may have stabilised the DNA and masked any heat sensitivity of the crosslink, was removed by a phenol/chloroform extraction prior to thermal treatment and assay. The CMA-reacted DNA was heated (10 min DNA fragments is shown in Figure 5 . Heat lability of all CMAinduced blockage sites was observed with exposure to increasing temperatures. A quantitative analysis of the intensity of the first nine exonuclease blockage sites is presented in Figure 7 . Although some clear differences of thermal stability of CMAinduced adducts were evident (midpoint melting temperature of 63°C and 70°C for blockage sites 1 and 8 respectively) there is an overall similarity of stability for most of the sites, with the average melting temperature being 66 ± 1 °C (standard deviation) for sites 2-9. If the heat lability was the same for all sites, the thermal profile would be identical for each site. This is not the case as indicated by the enhanced blockages detected at 60°C for some sites (4,9) relative to 20°C (Figure 7 ), indicative of a slower rate of loss of CMA-induced adducts at these sites compared to the remaining sites. It was not possible to determine a meaningful melting temperature for sites 10-12 because of the additional amount of exonuclease reaching these sites (compared to sites 1-9) at higher temperatures. 
Site of attachment
While CMA is known to bind guanine residues (14) the reactive DNA centres remain unknown. Spectral analysis of the synthetic polynucleotide poly(dG-dC) reacted with CMA revealed the presence of a visible spectrum with an absorbance maxima at 508 nm. The visible spectrum was identical to that of Adriamycininduced adducts of DNA (unpublished results) and reveals the involvement of the CMA chromophore as part of the adduct (Figure 8 ). In contrast, reaction with poly(dl-dC) yielded no spectra] evidence of CMA binding, implicating the requirement of the N 2 of guanine for DNA binding by CMA.
DISCUSSION
Interstrand crosslinklng
The formation of DNA interstrand crosslinks has long been implicated in the cellular mechanism of action of CMA (11, 12, (20) (21) (22) (23) . We have used a simple, yet direct assay to demonstrate die formation of CMA-induced DNA interstrand crosslinks in vitro (Figure 2 ). Consistent with previous in vitro studies (20) , crosslink formation was rapid and showed no requirement for drug activation. The drug concentration required to achieve maximal crosslinking in vitro was relatively high (micromolar), compared with that required (nanomolar) for cellular studies (20) . This difference suggests that while metabolic activation of CMA is not mandatory for interstrand crosslink formation, the cellular environment greatly enhances the levels of such crosslinks attained in vivo.
Sequence specificity All high intensity X-exonuclease blockage site began consistently 3-5 nucleotides prior to, and continued up to, 5'-GG sequences. This staggered blockage pattern has been seen previously at sites of platination and appears to be a general characteristic of steric inhibition of X-exonuclease by such adducts (24) . The detection of 5 '-GG sequences as the dominant site of CMA-induced adducts confirms similar results reported recendy for in vitro transcription footprinting detection of such adducts where these sequences were shown to be sites of intrastrand crosslinking (14) . The Xexonuclease was also blocked prior to 5'-CC sequences, presumably reflecting intrastrand crosslinks on the non-digested strand. In this context it is interesting to note that E.coli RNA polymerase also exhibited the ability to detect intrastrand crosslinks on both strands of the DNA (14) . The sole exonuclease blockage she at an isolated sequence not associated with 5'-GG, is a 5'-CGC sequence at position 60 ( Figure 6 ). It is therefore not possible from this data alone to indicate whether 5'-GC or 5'-CG may be involved as a site of alkylation. However, in vitro footprinting studies indicate that the CMA-induced adducts are at 5'-GC sequences, and that this is therefore the likely site of interstrand crosslinking. CMAinduced adducts were not observed at most isolated 5'-GC and 5'-CG sites because of the low CMA concentration employed in this work, and also because of the low reactivity known for these sites compared to 5'-GG sites (14) .
Thermal stability
The inability of CMA to induce stable DNA interstrand crosslinks was unexpected since several different methods have been used to demonstrate their formation both in vitro and in cell culture systems (11, 12, (20) (21) (22) (23) . While each method required denaturation of drug-treated DNA, all employed alkali for this purpose, either pH 12 for alkaline elution assays (12, 23, 25) , pH 11.8 for fluorescence renaturation assay (20, 26) and pH 12 for alkaline electrophoresis (18, 27) . The use of heat to denature CMA-reacted DNA revealed a lability of interstrand crosslinks to high temperatures (Figures 3 and 4) . It was therefore important to assess the lability of both the CMA-induced adducts and CMAinduced interstrand crosslinks.
The midpoint melting temperature was 70°C for the loss of interstrand crosslinks in 45 % formamide in the gel electrophoresis crosslinking assay. This temperature reflects an average of the most stable linkages involved since only one crosslink is required for each 3,000 bp DNA fragment to maintain crosslinked DNA in this assay. In contrast, the midpoint melting temperature was 66°C for the sole 5'-GC apparent interstrand crosslinking site detected in die 186 bp DNA in the exonuclease assay. Given that the stability of intrastrand crosslinks varied from 66-70°C, a similar range might be anticipated for the diermal stability of interstrand crosslinks. An additional complexity which arises when comparing the thermal stabilities of interstrand and intrastrand crosslinks is that it was necessary to heat the DNA in 45% formamide for die gel electrophoresis assay (the stability of DNA in buffer alone is 87° C) and it is difficult to assess the effect of the formamide in comparison to the exonuclease assay where formamide was not present. Overall, it appears that the interstrand crosslink is lost at a temperature (approximately 70°Q where CMA-induced adducts are lost.
Nature of the crosslink It has been shown by others that X-exonuclease demonstrates a limited ability to detect lesions on DNA. It is sensitive to alkylation of guanine N 2 (minor groove) but only those guanine N 7 alkylations (major groove) which perturb the DNA helix (24) . The ability of X-exonuclease to detect CMA binding to DNA therefore implicates these two positions as possible sites on the guanine residue for drug attachment. Of these two positions the N 2 of guanine has now been clearly implicated (by direct quantitation of adduct levels detected with DNA lacking this group) as necessary for adduct formation.
The present evidence that the DNA adduct contains the anthracycline chromophore and die recent evidence that die morpholino ring system comprises part of the adduct (28) are bodi consistent with the notion that the adduct forms by displacement of die cyano moiety, resulting in die formation of a reactive iminium centre capable of DNA alkylation (11, 22) . Given the present evidence diat the N 2 of guanine is also involved, tiiis suggests diat one bond associated with adduct formation is likely to be an aminal linkage (N-C-N) between the 3-position of die morpholino ring and the N 2 of guanine. Such an aminal linkage has previously been observed with saframycin A (29, 30) and anthramycin (31, 32) and in both cases the N 2 of guanine is also involved in this bond. It is also significant diat in bodi cases die adducts also exhibited a heat lability (29) (30) (31) (32) similar to diat observed widi die CMA-induced adducts, characteristic of diis inherendy unstable linkage (32) . Saframycin A adducts also involve die elimination of an a-cyano group, resulting in a reactive iminium centre capable of DNA alkylation, in a manner analogous to diat proposed for die CMA-induced adduct (29) .
The possibility diat die heat lability of die adducts could be associated witii a depurination model has also been considered. However, exposure of die alkylated DNA to piperidine at 90°C did not reveal any strand breakage characteristic of depurination (data not shown), and such a model has dierefore been rejected.
The nature of die second end of die crosslink remains unclear. Given die similar heat lability of bodi apparent intra-and interstrand crosslinks, die most likely possibility is that loss of one end of the crosslink destabilises die second site of attachment sufficiendy to release die drug from DNA. Such an unstable and reversible bond could well involve a Schiff base between die carbonyl at C-13 and an amino group of a neighbouring guanine residue.
CONCLUSIONS
Bodi intrastrand and interstrand crosslinks induced in DNA in vitro are heat labile, widi a midpoint melting temperature of 70°C after 10 min exposure to heat. The reactive centres for die crosslinks have not yet been fully elucidated-an aminal linkage appears to be involved at one end (between die morpholino 3 position and N 2 of guanine), while die nature of die second site of attachment remains unclear. It is now important to establish die chemistry involved in tiiese crosslinks, and tiieir lability since diis may provide new avenues of approach to die design of improved crosslinking agents for anticancer chemotiierapy.
